A study comparing several dose levels of LY3015014 in patients with high cholesterol studying the safety and ability of LY3015014 to reduce cholesterol

Update Il y a 5 ans
Reference: EUCTR2013-000622-55

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to assess the mean percentage change from baseline to week 16 in low-density lipoprotein cholesterol (LDL-C) measured using beta quantification with LY3015014 compared with placebo, in patients with primary hypercholesterolemia, when added to statin and diet (or diet alone in statin-intolerant patients) with or without ezetimibe.


Inclusion criteria

  • Primary hypercholesterolaemia